87.8%
lung adenocarcinomaanti-GBM diseaseAnti-glomerular basement membrane (anti-GBM) diseaseacute renal failurelung cancerpembrolizumabrenal replacement therapy
…he case of a man in his 60s receiving the ICI pembrolizumab for lung adenocarcinoma, who presented with acute renal failure requiring renal replace…